Europe Biodefense Market Size

Europe Biodefense Market By Product (Anthrax, Smallpox, Botulism, Radiation/nuclear, and Other Products), By Country, Industry Analysis and Forecast, 2020 - 2026

Europe Biodefense Market By Product (Anthrax, Smallpox, Botulism, Radiation/nuclear, and Other Products), By Country, Industry Analysis and Forecast, 2020 - 2026

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : February-2021 | Number of Pages : 68 | Format : PDF

TABLE 1 Europe Biodefense Market, 2016 - 2019, USD Million
TABLE 2 Europe Biodefense Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Bio-defense Market
TABLE 4 Approvals– Bio-defense Market
TABLE 5 Acquisition and Mergers– Bio-defense Market
TABLE 6 Europe Biodefense Market by Product, 2016 - 2019, USD Million
TABLE 7 Europe Biodefense Market by Product, 2020 - 2026, USD Million
TABLE 8 Europe Anthrax Market by Country, 2016 - 2019, USD Million
TABLE 9 Europe Anthrax Market by Country, 2020 - 2026, USD Million
TABLE 10 Europe Smallpox Market by Country, 2016 - 2019, USD Million
TABLE 11 Europe Smallpox Market by Country, 2020 - 2026, USD Million
TABLE 12 Europe Botulism Market by Country, 2016 - 2019, USD Million
TABLE 13 Europe Botulism Market by Country, 2020 - 2026, USD Million
TABLE 14 Europe Radiation/nuclear Market by Country, 2016 - 2019, USD Million
TABLE 15 Europe Radiation/nuclear Market by Country, 2020 - 2026, USD Million
TABLE 16 Europe Other Product Market by Country, 2016 - 2019, USD Million
TABLE 17 Europe Other Product Market by Country, 2020 - 2026, USD Million
TABLE 18 Europe Biodefense Market by Country, 2016 - 2019, USD Million
TABLE 19 Europe Biodefense Market by Country, 2020 - 2026, USD Million
TABLE 20 Germany Biodefense Market, 2016 - 2019, USD Million
TABLE 21 Germany Biodefense Market, 2020 - 2026, USD Million
TABLE 22 Germany Biodefense Market by Product, 2016 - 2019, USD Million
TABLE 23 Germany Biodefense Market by Product, 2020 - 2026, USD Million
TABLE 24 UK Biodefense Market, 2016 - 2019, USD Million
TABLE 25 UK Biodefense Market, 2020 - 2026, USD Million
TABLE 26 UK Biodefense Market by Product, 2016 - 2019, USD Million
TABLE 27 UK Biodefense Market by Product, 2020 - 2026, USD Million
TABLE 28 France Biodefense Market, 2016 - 2019, USD Million
TABLE 29 France Biodefense Market, 2020 - 2026, USD Million
TABLE 30 France Biodefense Market by Product, 2016 - 2019, USD Million
TABLE 31 France Biodefense Market by Product, 2020 - 2026, USD Million
TABLE 32 Russia Biodefense Market, 2016 - 2019, USD Million
TABLE 33 Russia Biodefense Market, 2020 - 2026, USD Million
TABLE 34 Russia Biodefense Market by Product, 2016 - 2019, USD Million
TABLE 35 Russia Biodefense Market by Product, 2020 - 2026, USD Million
TABLE 36 Spain Biodefense Market, 2016 - 2019, USD Million
TABLE 37 Spain Biodefense Market, 2020 - 2026, USD Million
TABLE 38 Spain Biodefense Market by Product, 2016 - 2019, USD Million
TABLE 39 Spain Biodefense Market by Product, 2020 - 2026, USD Million
TABLE 40 Italy Biodefense Market, 2016 - 2019, USD Million
TABLE 41 Italy Biodefense Market, 2020 - 2026, USD Million
TABLE 42 Italy Biodefense Market by Product, 2016 - 2019, USD Million
TABLE 43 Italy Biodefense Market by Product, 2020 - 2026, USD Million
TABLE 44 Rest of Europe Biodefense Market, 2016 - 2019, USD Million
TABLE 45 Rest of Europe Biodefense Market, 2020 - 2026, USD Million
TABLE 46 Rest of Europe Biodefense Market by Product, 2016 - 2019, USD Million
TABLE 47 Rest of Europe Biodefense Market by Product, 2020 - 2026, USD Million
TABLE 48 Key Information –Xoma Corporation
TABLE 49 Key Information – Altimmune, Inc.
TABLE 50 Key Information – Emergent BioSolutions, Inc.
TABLE 51 Key Information – Dynavax Technologies Corporation
TABLE 52 Key Information – SIGA Technologies, Inc.
TABLE 53 key information – Elusys Therapeutics, Inc.
TABLE 54 key Information – Ichor Holdings, Ltd.
TABLE 55 Key Information – Cleveland BioLabs, Inc.
TABLE 56 key information – Bavarian Nordic A/S
TABLE 57 Key Information – Alnylam Pharmaceuticals, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 3 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Jul – 2020, Jul) Leading Players
FIG 4 Recent strategies and developments: Altimmune, Inc.
FIG 5 Recent strategies and developments: Emergent BioSolutions, Inc.

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities